All Stories

  1. Valve Replacement With Decellularized Homografts may Impede Solid Organ Transplantation
  2. Perspectives of Indigenous Peoples on Home Dialysis: A Systematic Review and Meta-Synthesis of Qualitative Studies
  3. Improving Time to Kidney Transplant Listing: A Single Center Quality Improvement Initiative
  4. Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with and without Advanced CKD
  5. Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis
  6. Sensing Dying Cells in Health and Disease: The Importance of Kidney Injury Molecule-1
  7. Sodium-glucose co-transporter 2 inhibitors in patients with chronic kidney disease
  8. CENtral blood pressure Targeting: a pragmatic RAndomized triaL in advanced Chronic Kidney Disease (CENTRAL-CKD): A Clinical Research Protocol
  9. Electronic Decision Support for Deprescribing in Patients on Hemodialysis: Clinical Research Protocol for a Prospective, Controlled, Quality Improvement Study
  10. Transition From Pediatric to Adult Nephrology Care: Program Report of a Single-Center Experience
  11. Volume Status Assessment by Lung Ultrasound in End-Stage Kidney Disease: A Systematic Review
  12. Lived Experiences of Hemodialysis Health Care Workers during the COVID-19 Pandemic: A Qualitative Study from the Quebec Renal Network
  13. Identifying Modifiable System-Level Barriers to Living Donor Kidney Transplantation
  14. Innate Immunity and SARS-CoV-2 Vaccine Response in Hemodialysis Patients
  15. A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+T cell profile
  16. Defective KIM-1 phagocytosis does not predispose to acute graft dysfunction after kidney transplantation in humans
  17. Lived Experiences of Patients Receiving Hemodialysis during the COVID-19 Pandemic: A Qualitative Study from the Quebec Renal Network
  18. SARS-CoV-2 Vaccine Mandates for Patients on the Kidney Transplant Waitlist
  19. Accessing hemodialysis clinics during the COVID-19 pandemic
  20. Five Things to Know About Intradialytic Hypertension
  21. Opioid prescribing practices in chronic kidney disease: a population-based cohort study
  22. Worldwide Early Impact of COVID-19 on Dialysis Patients and Staff and Lessons Learned: A DOPPS Roundtable Discussion
  23. Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis
  24. Recombinant apoptosis inhibitor of macrophage protein reduces delayed graft function in a murine model of kidney transplantation
  25. Short-term antibody response and tolerability after one dose of BNT162b2 vaccine in patients receiving hemodialysis: A report from the Quebec Renal Network COVID-19 study
  26. Quality of Life and Hemodynamic Effects of Switching From Hemodialysis to Hemodiafiltration: A Canadian Controlled Cohort Study
  27. Re-Envisioning the Canadian Nephrology Trials Network: A Can-SOLVE-CKD Stakeholder Meeting of Patient Partners and Researchers
  28. Frailty and the Kidney Transplant Wait List: Protocol for a Multicenter Prospective Study
  29. COVID-19 Status, Symptom Burden, and Characteristics of Dialysis Patients Residing in Areas of Community Transmission: Research Letter
  30. Management of Outpatient Hemodialysis During the COVID-19 Pandemic: Recommendations From the Canadian Society of Nephrology COVID-19 Rapid Response Team
  31. Proceedings From a Canadian Nephrology Forum: Nephrology Is Back
  32. Use of the FRAIL Questionnaire in Patients With End-Stage Kidney Disease
  33. Effects of Frequent Hemodialysis on Perceived Caregiver Burden in the Frequent Hemodialysis Network Trials
  34. The Author Replies:
  35. The Authors Reply
  36. Hypertension in pregnancy afterEscherichia coliO157:H7 gastroenteritis: a cohort study
  37. Canadian Society of Nephrology Guidelines for the Management of Patients With ESRD Treated With Intensive Hemodialysis
  38. Dialysate Calcium Concentration and Mineral Metabolism in Long and Long-Frequent Hemodialysis: A Systematic Review and Meta-analysis for a Canadian Society of Nephrology Clinical Practice Guideline
  39. Vascular Access for Intensive Maintenance Hemodialysis: A Systematic Review for a Canadian Society of Nephrology Clinical Practice Guideline
  40. Modifiable variables affecting interdialytic weight gain include dialysis time, frequency, and dialysate sodium
  41. Pre to post-dialysis plasma sodium change better predicts clinical outcomes than dialysate to plasma sodium gradient in quotidian hemodialysis
  42. Risk of Vascular Access Complications with Frequent Hemodialysis
  43. A multinational cohort study of in-center daily hemodialysis and patient survival
  44. Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis Network (FHN) Trials
  45. Case report: Atenolol overdose successfully treated with hemodialysis
  46. Biofeedback dialysis for hypotension and hypervolemia: a systematic review and meta-analysis
  47. Cardiovascular disease after Escherichia coli O157:H7 gastroenteritis
  48. Early dialysis
  49. Patient experiences and preferences on short daily and nocturnal home hemodialysis
  50. Intensive Hemodialysis Associates with Improved Survival Compared with Conventional Hemodialysis
  51. Survival with Three-Times Weekly In-Center Nocturnal Versus Conventional Hemodialysis
  52. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial
  53. Urine Volume and Change in Estimated GFR in a Community-Based Cohort Study
  54. Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada
  55. Dipstick Proteinuria as a Screening Strategy to Identify Rapid Renal Decline
  56. Peritoneal dialysis vs hemodialysis: time to end the debate?
  57. Hemodialysis in a Satellite Unit: Clinical Performance Target Attainment and Health-Related Quality of Life
  58. Burden on caregivers as perceived by hemodialysis patients in the Frequent Hemodialysis Network (FHN) trials
  59. Clinical Practice Guidelines and Recommendations on Peritoneal Dialysis Adequacy 2011
  60. Design and Rationale of Health-Related Quality of Life and Patient-Reported Outcomes Assessment in the Frequent Hemodialysis Network Trials
  61. International quotidian dialysis registry: Annual report 2010
  62. Long term risk for hypertension, renal impairment, and cardiovascular disease after gastroenteritis from drinking water contaminated with Escherichia coli O157:H7: a prospective cohort study
  63. Opioid and Benzodiazepine Use in End-Stage Renal Disease: A Systematic Review
  64. Recruitment and Training for Home Hemodialysis: Experience and Lessons from the Nocturnal Dialysis Trial
  65. Risk of Pregnancy-Related Hypertension Within 5 Years of Exposure to Drinking Water Contaminated With Escherichia coli O157:H7
  66. Results of a randomized controlled trial on statin use in dialysis patients had no influence on statin prescription
  67. International quotidian dialysis registry: Annual report 2009
  68. Factors that led to the Walkerton tragedy
  69. Relationship between Escherichia coli O157:H7 and diabetes mellitus
  70. Renal prognosis of toxigenic Escherichia coli infection
  71. Risk of pregnancy-related hypertension within five years of exposure to bacteria-contaminated drinking water
  72. TTP/HUS: observational studies generate hypotheses that lead to randomized controlled trials
  73. PSYCHOSOCIAL FACTORS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: Frequent Hemodialysis and Psychosocial Function
  74. Elevated Blood Pressure in Relation to Overweight and Obesity Among Children in a Rural Canadian Community
  75. The International Quotidian Dialysis Registry: Annual report 2008
  76. The International Quotidian Hemodialysis Registry: Rationale and challenges
  77. Can Extracellular Fluid Volume Expansion in Hemodialysis Patients Be Safely Reduced Using the Hemocontrol Biofeedback Algorithm? A Randomized Trial
  78. Albuminuria and Estimated GFR 5 Years After Escherichia coli O157 Hemolytic Uremic Syndrome: An Update
  79. Excessive fluid intake as a novel cause of proteinuria
  80. The International Quotidian Dialysis Registry: Annual Report 2007
  81. Frequent Hemodialysis Network (FHN) randomized trials: Study design
  82. The International Quotidian Dialysis Registry: Annual report 2006
  83. Randomized Trials of Frequent Hemodialysis – Infinite Possibilities
  84. Diabetes in Diarrhea-Associated Hemolytic Uremic Syndrome: A Systematic Review and Meta-Analysis
  85. Risk of hypertension and reduced kidney function after acute gastroenteritis from bacteria-contaminated drinking water
  86. The International Quotidian Dialysis Registry: Annual report 2005
  87. Microalbuminuria three years after recovery from Escherichia coli O157 hemolytic uremic syndrome due to municipal water contamination
  88. Is more frequent hemodialysis beneficial and what is the evidence?
  89. The International Quotidian Hemodialysis Registry: Rationale and methods
  90. Long-term Renal Prognosis of Diarrhea-Associated Hemolytic Uremic Syndrome
  91. Adequacy of quotidian hemodialysis
  92. The impact of quotidian hemodialysis on nutrition
  93. Volume control and blood pressure management in patients undergoing quotidian hemodialysis